CHOPCHOP v3: expanding the CRISPR web toolbox beyond genome editing

Abstract The CRISPR–Cas system is a powerful genome editing tool that functions in a diverse array of organisms and cell types. The technology was initially developed to induce targeted mutations in DNA, but CRISPR–Cas has now been adapted to target nucleic acids for a range of purposes. CHOPCHOP is a web tool for identifying CRISPR–Cas single guide RNA (sgRNA) targets. In this major update of CHOPCHOP, we expand our toolbox beyond knockouts. We introduce functionality for targeting RNA with Cas13, which includes support for alternative transcript isoforms and RNA accessibility predictions. We incorporate new DNA targeting modes, including CRISPR activation/repression, targeted enrichment of loci for long-read sequencing, and prediction of Cas9 repair outcomes. Finally, we expand our results page visualization to reveal alternative isoforms and downstream ATG sites, which will aid users in avoiding the expression of truncated proteins. The CHOPCHOP web tool now supports over 200 genomes and we have released a command-line script for running larger jobs and handling unsupported genomes. CHOPCHOP v3 can be found at https://chopchop.cbu.uib.no

[1]  Tetsushi Sakuma,et al.  Establishment of expanded and streamlined pipeline of PITCh knock-in – a web-based design tool for MMEJ-mediated gene knock-in, PITCh designer, and the variations of PITCh, PITCh-TG and PITCh-KIKO , 2017, Bioengineered.

[2]  A. Regev,et al.  RNA targeting with CRISPR-Cas 13 a , 2017 .

[3]  Aviv Regev,et al.  RNA targeting with CRISPR–Cas13 , 2017, Nature.

[4]  Aviv Regev,et al.  Nucleic acid detection with CRISPR-Cas13a/C2c2 , 2017, Science.

[5]  Sungroh Yoon,et al.  Deep learning improves prediction of CRISPR–Cpf1 guide RNA activity , 2018, Nature Biotechnology.

[6]  G. Church,et al.  Unraveling CRISPR-Cas9 genome engineering parameters via a library-on-library approach , 2015, Nature Methods.

[7]  Meagan E. Sullender,et al.  Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9 , 2015, Nature Biotechnology.

[8]  James A. Gagnon,et al.  Whole-organism lineage tracing by combinatorial and cumulative genome editing , 2016, Science.

[9]  S. Konermann,et al.  Transcriptome Engineering with RNA-Targeting Type VI-D CRISPR Effectors , 2018, Cell.

[10]  Christopher M. Vockley,et al.  RNA-guided gene activation by CRISPR-Cas9-based transcription factors , 2013, Nature Methods.

[11]  Charles E. Vejnar,et al.  CRISPRscan: designing highly efficient sgRNAs for CRISPR/Cas9 targeting in vivo , 2015, Nature Methods.

[12]  Kornel Labun,et al.  Accurate analysis of genuine CRISPR editing events with ampliCan. , 2019, Genome research.

[13]  Lei S. Qi,et al.  The New State of the Art: Cas9 for Gene Activation and Repression , 2015, Molecular and Cellular Biology.

[14]  David K. Gifford,et al.  Predictable and precise template-free CRISPR editing of pathogenic variants , 2018, Nature.

[15]  Eli J. Fine,et al.  DNA targeting specificity of RNA-guided Cas9 nucleases , 2013, Nature Biotechnology.

[16]  D. Stainier,et al.  Genetic compensation triggered by mutant mRNA degradation , 2019, Nature.

[17]  Kira S. Makarova,et al.  Cas13b is a Type VI-B CRISPR-associated RNA-Guided RNase differentially regulated by accessory proteins Csx27 and Csx28 , 2016, bioRxiv.

[18]  Tessa G Montague,et al.  Internal guide RNA interactions interfere with Cas9-mediated cleavage , 2016, Nature Communications.

[19]  Edward M. Callaway,et al.  In vivo genome editing via CRISPR/Cas9 mediated homology-independent targeted integration , 2016, Nature.

[20]  Luke A. Gilbert,et al.  CRISPR-Mediated Modular RNA-Guided Regulation of Transcription in Eukaryotes , 2013, Cell.

[21]  Clifford A. Meyer,et al.  Sequence determinants of improved CRISPR sgRNA design , 2015, Genome research.

[22]  Tetsushi Sakuma,et al.  MMEJ-assisted gene knock-in using TALENs and CRISPR-Cas9 with the PITCh systems , 2015, Nature Protocols.

[23]  Sergey A. Shmakov,et al.  Cas13b is a Type VI-B CRISPR-associated RNA-Guided RNase differentially regulated by accessory proteins Csx27 and Csx28 , 2016, bioRxiv.

[24]  Yarden Katz,et al.  Multiplexed activation of endogenous genes by CRISPR-on, an RNA-guided transcriptional activator system , 2013, Cell Research.

[25]  Le Cong,et al.  Multiplex Genome Engineering Using CRISPR/Cas Systems , 2013, Science.

[26]  Eric S. Lander,et al.  C2c2 is a single-component programmable RNA-guided RNA-targeting CRISPR effector , 2016, Science.

[27]  Max J. Kellner,et al.  RNA editing with CRISPR-Cas13 , 2017, Science.

[28]  Peter F. Stadler,et al.  ViennaRNA Package 2.0 , 2011, Algorithms for Molecular Biology.

[29]  Sergey A. Shmakov,et al.  Cas 13 b Is a Type VIB CRISPR-Associated RNA-Guided RNase Differentially Regulated by Accessory Proteins Csx 27 and Csx 28 , 2017 .

[30]  Morgan L. Maeder,et al.  CRISPR RNA-guided activation of endogenous human genes , 2013, Nature Methods.

[31]  Thualfeqar Almohanna.  RNA Editing with CRISPR Cas-13 , 2021, Academia Letters.

[32]  F. Sedlazeck,et al.  Targeted Nanopore Sequencing with Cas9 for studies of methylation, structural variants, and mutations , 2019, bioRxiv.

[33]  Luke A. Gilbert,et al.  Repurposing CRISPR as an RNA-Guided Platform for Sequence-Specific Control of Gene Expression , 2013, Cell.

[34]  Tessa G. Montague,et al.  Efficient Mutagenesis by Cas9 Protein-Mediated Oligonucleotide Insertion and Large-Scale Assessment of Single-Guide RNAs , 2014, PloS one.

[35]  Sergey A. Shmakov,et al.  CRISPR EVOLUTION C 2 c 2 is a single-component programmable RNA-guided RNA-targeting CRISPR effector , 2016 .

[36]  Y. Ebenstein,et al.  Selective nanopore sequencing of human BRCA1 by Cas9-assisted targeting of chromosome segments (CATCH) , 2018, Nucleic acids research.

[37]  John E. Dueber,et al.  CRISPR-guided DNA polymerases enable diversification of all nucleotides in a tunable window , 2018, Nature.